GlassScriptPhysician profile
Khalil Semaan
NPI 1447547070
$2,550.77
in general payments reported to CMS, 2019-2025
23 companies · $719 in 2025
The $719 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $65.34 · 2021: $292 · 2022: $164 · 2023: $502 · 2024: $566 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751 · Entertainment: $35.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.38 |
| Entertainment | $35.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $342.71 | 2022-2025 | Infuse, Scoutpro Osmolarity System, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $290.24 | 2023-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $242.32 | 2022-2025 | Rocklatan, Tryptyr, Clareon |
| Sun Pharmaceutical Industries INC. | $173.36 | 2019-2025 | |
| Oyster Point Pharma, INC. | $160.28 | 2022-2024 | Tyrvaya |
| Glaukos Corporation | $137.40 | 2025 | Idosetr |
| Mallinckrodt Hospital Products INC. | $128.75 | 2025 | Acthar |
| Rxsight INC | $125.00 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Amgen INC. | $118.85 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $116.13 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $103.52 | 2019-2021 | |
| Ocular Therapeutix, INC. | $97.75 | 2021 | |
| Thea Pharma INC. | $86.19 | 2023-2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $80.05 | 2020-2021 | |
| Biotissue Holdings INC. | $73.80 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $61.02 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $47.06 | 2025 | Xdemvy |
| Optos, INC. | $35.89 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rayner Intraocular Lenses Limited | $30.42 | 2025 | Omidria |
| New World Medical,INC. | $30.02 | 2019 | |
| Harrow Eye, LLC | $28.50 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $23.76 | 2022 | |
| Coopervision INC. | $17.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil Semaan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.